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Urban and rural population exposure to ochratoxin A (OTA) in central zone of Portugal was investigated in three places: Coimbra,
Verride and Ereira.
The analytical method proposed for the determination of ochratoxin A involved extraction with chloroform-orthophosphoric acid,
cleanup through an immunoaffinity column (IAC), high performance liquid chromatography (HPLC) with spectrofluorimetric detection
(FD) for separation and identification of ochratoxin A, and confirmation with HPLC–FD after OTA methylation in serum. The limit of
quantification of the proposed method was 0.1 lg/L for serum and 0.05 lg/L for blood. OTA recoveries in serum ranged from 70.3% to
115.3% for levels at 0.25 lg/L and 0.5 lg/L, respectively, with a within-day RSD between 8.0% and 16.2%.
Ochratoxin A serum levels were evaluated in an hundred and four donors from Coimbra city, Verride, and Ereira. The study revealed
a frequency of detection of 100%. The ratio of ochratoxin A level in serum to whole blood was 2.0 ± 0.7.
The overall concentrations range from 0.25 to 2.49 lg/L, 0.14 to 1.91 lg/L, and 0.19 to 0.96 lg/L, for samples of Verride, Ereira, and
Coimbra, respectively. The mean concentration and standard deviation were 0.78 ± 0.53 lg/L, 0.44 ± 0.31 lg/L, and 0.42 ± 0.18 lg/L
for the same samples. A significant difference was found in Verride population (P-value = 0.000).
Levels of OTA are clearly higher in males from rural areas than in females. For all samples, a significant difference was found in
Verride male population (P-value = 0.014).
 2007 Elsevier Ltd. All rights reserved.
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Ochratoxin A (OTA) is a mycotoxin produced by
several Aspergillus and Penicillium species. Among Asper-
gillus species there are two in section Nigri and four in sec-
tion Circumdati, formerly the Aspergillus ochraceus group,
now referred to as Aspergillus alutaceus (Thuvander et al.,
2001; Marquardt and Frolich, 1992; Zimmerli and Dick,
1995; Valenta, 1998). The presence of OTA in human
blood or serum is related to the ingestion of several
contaminated food. Penicillium verrucosum has been con-
sistently associated with cereals, Aspergillus species with0278-6915/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.fct.2007.10.012
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E-mail address: cmlino@ci.uc.pt (C.M. Lino).coffee beans, and Aspergillus niger and carbonarius have
been isolated from dried vine fruit (Thuvander et al.,
2001; Pena et al., 2005). Other food items are also contam-
inated, cow’s and human milk (Zimmerli and Dick, 1995;
Valenta, 1998; Breitholtz-Emanuelson et al., 1993), animal
tissues, muscle, and organs, eggs (Marquardt and Frolich,
1992; Valenta, 1998; Moreno Guillamont et al., 2005),
pulses, wine and beer (Thuvander et al., 2001; Castellari
et al., 2000; Visconti et al., 2000; Leitner et al., 2002).
Recognized as carcinogenic, teratogenic, immunotoxic,
genotoxic, as well nephrotoxic (Thuvander et al., 2001;
Marquardt and Frolich, 1992; Zimmerli and Dick, 1995;
Valenta, 1998; Leitner et al., 2002), the evaluation of
OTA levels in different types of populations is unquestion-
able to provide data on exposure and evaluate the possible
human health risk to OTA.
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quently found in human blood due to the long elimination
half-life (about 35 days in serum), as consequence of its
binding to plasma proteins, its enterohepatic circulation
and its re-absorption from urine. This renders OTA among
the most frequent mycotoxins contaminants found in
human blood all over the world (Pena et al., 2006).
Several studies carried out in Europe (Zimmerli and
Dick, 1995; Peraica et al., 1999, 2001; Jimenez et al., 1998),
Africa (Kane et al., 1991; Singare-Tigori et al., 2006), Asia
(Assaf et al., 2004) and Canada (Scott et al., 1998) report
the presence of OTA in human serum or plasma, clearly
demonstrating the human exposure to this mycotoxin.
Investigations on OTA occurrence in different countries
have shown that it occurs in their populations with different
mean concentrations in plasma or serum. These levels
oscillated between 0.18 lg/L, in Norway, and 1.09 lg/L,
in United Kingdom (Thuvander et al., 2001). In most
countries, the detection frequency is 100% (Thuvander
et al., 2001; Zimmerli and Dick, 1995) with exception of
Yugoslavia, Germany, and Croatia, with 6.6%, 98%, and
59.4%, respectively (Marquardt and Frolich, 1992; Gareis
et al., 2001; Peraica et al., 1999).
The aim of this work was to validate a high performance
liquid chromatography with spectrofluorimetric detection
(HPLC–FD) method for the determination of ochratoxin
A levels in blood and serum, and assess the correlation fac-
tor between the OTA levels in serum and in whole blood.
The method was applied to quantify the levels and the fre-
quency of detection in twenty blood samples and 104 serum
samples of different types of populations from central zone
of Portugal, urban and rural, in order to evaluate its expo-
sure degree.2. Experimental
2.1. Solvents and materials
HPLC grade acetonitrile, chloroform, toluene, and methanol were
purchased from Carlo Erba (Milan, Italy). Acetic acid, hydrochloride
acid, sodium hydroxide, potassium chloride, potassium dihydrogenphos-
phate, anhydrous disodium hydrogenphosphate, sodium chloride, and
85% orthophosphoric acid were obtained from Merck (Darmstadt, Ger-
many). Water was purified by distillation and passage through a Milli-Q
system (Millipore, Bedford, MA, USA). OTA with purity grade P98%,
and boron trifluoride 14% methanolic solution were purchased from
Sigma Chemical Co. (St. Louis, MO, USA).
Immunoaffinity columns (IAC) OchratestTM were from VICAM
(Watertown, USA), centrifuge Meditronic S-599 from Selecta (Barcelona,
Spain), vortex mixer from Retsh (Haan, Germany), and ultrasonic bath
RK 100 from Sonorex (Berlin, Germany).Table 1
Accuracy and precision of analytical methodology for human whole blood
and serum
Fortification (lg/L) Whole blood R ± SD* (%) Serum R ± SD* (%)
0.25 114.3 ± 22.9 70.3 ± 16.2
0.5 82.1 ± 20.6 115.3 ± 13.1
1.25 98.3 ± 13.3 88.0 ± 8.0
2.0 74.3 ± 10.6 95.7 ± 8.1
* n = 3.2.2. HPLC system and chromatographic conditions
The HPLC system consisted of a pump, model 307 (Gilson Medical
Electronics, France), an 20 lL injection valve, model 7125 (Rheodyne,
Cotati, California, USA), a guard column, C18 – 5 lm Nucleosil 120 KS
(30 · 4 mm i.d.), and a column, C18 – 5 lm Nucleosil 100 KS
(250 · 4.6 mm i.d.). A spectrofluorimeter, model LS-3B (Perkin–Elmer,
USA), was connected to the HPLC. The analyses were made using 333 nmfor excitation and 460 nm for emission. An integrator, model 3390A
(Hewlett-Packard, Philadelphia, USA), was used to measure peak areas.
The mobile phase consisted of a mixture of water:acetonitrile:glacial
acetic acid (49.5:49.5:1.0 v/v/v) and the flow rate was 1 mL/min.
2.3. Extraction and clean-up
Two mL of whole blood or serum were added of 10 mL of a solution
containing 33.7 mL of 85% orthophosphoric acid and 118 g sodium
chloride per liter, and mixed for 1 min. After, 2 · 5 mL of chloroform were
added and intensively mixed for 3 min, and then centrifuged at 2500g,
15 min. The organic phase was evaporated to dryness at 30–40 C. The dry
extract was dissolved in 3 · 5 mL of PBS-methanol and passed through an
IAC column. After the solution had passed through the column, the
column was washed with water and dried by air. OTA was eluted with
3 mL methanol and the eluate evaporated at 30–40 C under a gentle
stream of nitrogen. The residue was dissolved in 250 lL of mobile phase
and injected in the HPLC system.
2.4. Validation studies
Linearity was evaluated in the range of 0.1–0.5 ng (5–25 lg/L). For
calibration curve, the stock solution was prepared at 5 lg/mL in tolu-
ene:acetic acid (99:1). Standard solution was prepared by evaporating
10 lL of stock solution at dryness, and diluting to 10 mL with mobile
phase. Work solutions were prepared by dissolving standard solutions in
mobile phase.
For fortification assays, the stock solution was prepared at 250 lg/mL
in toluene:acetic acid (99:1). Standard solution was prepared at 10 lg/mL,
and the work solution at 1 lg/mL. The recovery studies were made by
adding OTA solution prepared in toluene: acetic acid (99:1) to three
replicates of each one of the matrix involved in this study (Table 1).
2.5. Sampling and description of populations
The present study was carried out in 2002 in the central region of
Portugal, in the neighbourhood of Coimbra, the most important city of
this region, placed between Lisbon and Oporto. Samples were collected in
Coimbra city and two farming villages, Verride and Ereira, which are
located in the Mondego valley, about 30 km from Coimbra. Verride is on
the left bank at a higher level as opposed of Ereira which stays on the right
bank at river level.
All volunteers were asked to complete a rapid questionnaire about age,
clinical history, and occupation.
Blood samples from an hundred four donors from these three popula-
tions were collected. Blood samples of Coimbra donors were collected at the
Laboratory of Clinical Analysis of Faculty of Pharmacy, University of
Coimbra, from May to July 2002. Donors were aged between 21 and 57
(31 ± 10.7). Blood samples of Verride and Ereira donors were collected at
the respective Health Centers, from October to December 2001, and from
December 2001 to January 2002, respectively. In the first village, the donor
age varied between 26 and 92 (76 ± 10.9), and in the last one, it oscillated
from 19 to 88 (59 ± 15.1). Mean weights were 69 ± 13.7, 73 ± 10.9, and
69 ± 11.3, for Coimbra, Verride and Ereira donors, respectively. The study
included 29 samples from Coimbra (16 women and 13 men), 31 from Ver-
ride (17 women and 14 men), and 44 from Ereira (34 women and 10 men).
AB
C
Fig. 1. Chromatograms of OTA standard (A) (2.5 ng) (retention time
11.96), one sample containing 0.496 lg/L (B), and one serum sample
spiked at 1.25 lg/L (C).
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serum samples, or in 3 mL plastic tubes containing ethylenediaminetetr-
acetic acid for whole blood samples. Serum was obtained by heating the
tubes at 37 C for 3 h, and submitting it to centrifugation at 1500g for
10 min.
2.6. Chemical confirmation
The first confirmation was performed according to the method of
Zimmerli and Dick (1995): 200 lL of the extract was diluted to 2.5 ml with
methanol and 0.1 mL of 37% concentrated HCl was added. After standing
overnight at room temperature, the methanol was evaporated and the
residue dissolved in 250 lL of the mobile phase.
Another confirmation was carried out by following the procedure of
Castegnaro et al. (1998). In this way, sample extracts were evaporated to
dryness, 150 lL BF3 (14% methanolic solution) were added, and the
mixture was left at 60 C for 10 min. After evaporation, the residue was
dissolved in 150 lL water–acetonitrile–glacial acetic acid (49.5:49.5:1.0).
The OTA methyl esters were analyzed according to the HPLC method
described earlier.
2.7. Statistical analysis
Database management and statistical analysis were performed with the
SPSS 10.0 Microsoft version. The differences in the OTA levels between
different populations were tested with the Kruskal–Wallis test. P 6 0.05
(two-tailed) was considered to be statistically significant.
3. Results
3.1. Analytical method validation
The calibration curve was obtained using the linear
least-squares regression procedure of the peak area versus
the concentration. The correlation coefficient (r2) was
0.9914 in the range of 0.1–0.5 ng (5–25 lg/L).
For whole blood and serum matrices, accuracy and pre-
cision of the analytical methodology were adequate for all
the fortification levels evaluated (Table 1) and according to
international parameters (Hubner, 1998; Hill and Rey-
nolds, 1999; Swartz and Krull, 1998) The recovery, for
whole blood, varied between 74.3% to 114.3%, for levels
at 2 lg/L and 0.25 lg/L, and the precision oscillated
between 10.6% to 22.9% for levels at 2 lg/L and 0.25 lg/
L. For the serum matrix, the recovery varied between
70.3% to 115.3%, for levels at 0.25 lg/L and 0.5 lg/L,
and the precision oscillated between 8.0% to 16.2% for lev-
els at 1.25 lg/L and 0.25 lg/L. Fig. 1 shows the HPLC–FD
chromatograms of the OTA standard, one serum sample,
and one fortified serum sample.
The limit of quantification (LOQ) was determined by the
signal-to-noise ratio approach, defined as that level result-
ing in a signal-to-noise ratio of approximately 10:1. For
serum matrix, the limit of quantification was 0.1 lg/L,
and for whole blood 0.05 lg/L.
3.2. Confirmation by methylation with boron trifluoride
For confirmation, OTA was converted into OTA methyl
ester and two different procedures were evaluated. Positive
confirmation was based on the disappearance of the OTA
Table 2
Minimum, maximum, mean concentration of serum, and SD of OTA (lg/
L) in inhabitants of three places in central zone of Portugal
Coimbra Verride Ereira
Min 0.19 0.25 0.14
Max 0.96 2.49 1.91
Mean 0.42 0.78 0.44
Std. Dev. 0.18 0.53 0.31
Table 3
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OTA methyl ester, at a retention time of 21.3 min. The
recovery rate of the methyl ester was higher, 93%, for
boron trifluoride-methanol solution when compared with
the rate obtained when the method of Zimmerli and Dick
(1995) was used, 79%, with good blanks, in spite of the
appearance of one peak with a different retention time,
which did not interfere. For these reasons, the confirmation
of OTA in samples was performed according to the first
method.Mean concentration (lg/L) and SD of OTA in women (W) and men (M)













Mean 0.38 0.60 0.40 0.46 1.01 0.55
Std.
Dev
0.15 0.21 0.30 0.21 0.62 0.343.3. Relation between OTA levels in serum and blood
To establish the mean ratio of ochratoxin A level in
serum to whole blood, twenty samples were available.
The obtained ratio was 2.0 ± 0.7 (Fig. 2). This value agrees
with the ratio of 2.0 ± 0.1, obtained when 3 samples of
human blood and serum were analyzed, with the ratio
1.9 ± 0.1 achieved with 15 samples of pigs, or 1.7 obtained
with rats (Zimmerli and Dick, 1995).3.4. Evaluation of OTA in serum samples
For the evaluation of the OTA levels, the serum matrix
was chosen, once higher OTA levels and cleaner extracts
were obtained. A total of 104 samples of serum were ana-
lyzed under the described conditions and the frequency of
detection was 100%, at concentrations ranging between
0.14 and 2.49 lg/L.
The present study shows that the percentage of OTA
containing samples with levels higher than 2 lg/L was only
0.96%, being 2.49 lg/L the highest level.
Table 2 shows minimum and maximum levels, mean

















Levels of OA in Blood and Serum
Blood
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Serum/Blood = 2.0± 0.7
Fig. 2. Mean ratio of OTA levels in both matrices.serum of the inhabitants of three places of the central zone
of Portugal. The overall concentrations range from 0.25 to
2.49 lg/L, 0.14 to 1.91 lg/L, and 0.19 to 0.96 lg/L, for
samples of Verride, Ereira, and Coimbra, respectively.
The mean concentration and standard deviation were
0.78 ± 0.53 lg/L, 0.44 ± 0.31 lg/L, and 0.42 ± 0.18 lg/L
for the same samples. A significant difference was found
in Verride population (P-value = 0.000).
Mean concentration and SD of OTA in women (W) and
men (M) serum in the three places are shown in Table 3.
Levels of OTA are clearly higher in males of rural areas
than in females, but this statement was not so clear in
Coimbra. For all samples, a significant difference was
found only in Verride male population (P value = 0.014).
For women, the mean concentration and standard
deviation were 0.6 ± 0.21 lg/L, 0.40 ± 0.30 lg/L, and
0.38 ± 0.15 lg/L for samples of Verride, Ereira, and Coim-
bra, respectively. A significant difference was only found in
Verride females (P value = 0.002).
For men, the mean concentration and standard
deviation was 1.01 ± 0.62 lg/L, 0.55 ± 0.34 lg/L, and
0.46 ± 0.21 lg/L for the same samples. The samples of
the two villages showed higher levels, especially those from
Verride, than those from the Coimbra city. A significant
difference was found in Verride males (P value = 0.027).
No statistical differences were observed between sexes
within each one of the three studied populations (Verride:
P value = 0.088, Ereira: P-value = 0.161, and Coimbra
P-value = 0.346).
3.5. Evaluation of daily intake
In the studied populations, the estimated daily intake
(EDI), based on the equation of Breitholtz et al. (1991),
was 0.56 ng/kg b.w. per day in Coimbra (range 0.26–
1.29 ng/kg b.w. per day), 0.59 ng/kg b.w. per day in Ereira
(range 0.19–2.56 ng/kg b.w. per day), and 1.05 ng/kg b.w.
per day in Verride (range 0.34–3.35 ng/kg b.w. per day).
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The percentage of OTA containing samples with levels
higher than 2 lg/L differs from those of some countries.
In Spain, 5% of samples have levels above 2 lg/L, and in
France, in Alsace, Aquitaine, and Rhoˆne-Alpe rural areas,
2.6%, 10%, and 0.3% of samples had levels above 2 lg/L,
respectively. In Spain, in Italy, and in France (Aquitaine
area), the maximum values were 4 lg/L, 2 lg/L and
161 lg/L, respectively (Jimenez et al., 1998; Creppy et al.,
1993). The German population presents a median concen-
tration of 0.2 lg/L (Gareis et al., 2001). Higher maximum
levels have also been reported in other European countries,
such as Croatia, Denmark, and Poland (Peraica et al.,
1999; Jimenez et al., 1998) (Table 4). In Canada, the high-Table 4
Ochratoxin A in serum or plasma samples in some countries
Country % Detection LOQ
Tunisia
Healthy 71







































Verride 100est value was 2.37 lg/L, and only 3 of 144 samples
exceeded 2 lg/L (Scott et al., 1998).
The occurrence of higher levels in rural populations may
be related with different situations. One important factor is
due to the climate difference between the studied zones.
Verride and Ereira located in the Mondego valley present
a higher moisture grade, what probably contributes for
deficient procedures of conservation of cereals and other
food items. The highest consumption of alcoholic bever-
ages, different consumption habits, and regional food
intake patterns may contribute to this situation. Another
problem may be related to the local production of food
that may influence the OTA exposure. Comparing the three
populations, significant difference was found in Verride
group aged between 40 and 60 (P-value = 0.005). Also, aRange Mean References
Hassen et al. (2004)
nd–7.5 2.6 ± 2.3
17.4–140.5 44.4 ± 19
Grosso et al. (2003)
0.11–5.80 0.99 ± 1.28
0.12–8.06 0.53 ± 1.0
Petkova-Bocharova et al. (2003)
0.2–1.6 0.67 ± 0.24
0.1–10.9 2.01 ± 0.54
Brera et al. (2002)
0.94–3.28
0.53
0.12–2.84 0.56 Palli et al. (1999)
0.1–2 0.53 Jimenez et al. (1998)
nd–6.59 0.29 ± 0.51 Fillali et al. (2002)
0.1–0.87 0.17 ± 0.01 Assaf et al. (2004)






0.2–15.9 0.39 Peraica et al. (1999)
0.29–2.37 0.88 ± 0.35 Scott et al. (1998)
Thuvander et al. (2001)






0.5–4.0 0.7 Jimenez et al. (1998)
0.1–6 Creppy et al. (1993)
Zimmerli and Dick (1995)
0.06–2.14
0.11–6.02
1.3–4.8 0.3 Hald (1991)
This study
0.19–0.96 0.42 ± 0.18
0.14–1.91 0.44 ± 0.31
0.25–2.49 0.78 ± 0.53
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value = 0.027) and Ereira groups 71–80 years old.
In different countries such as France (Creppy et al.,
1993; Scott et al., 1998; Dragacci et al., 1999), Sweden
(Zimmerli and Dick, 1995; Scott et al., 1998), Tunisia
(Peraica et al., 1999; Scott et al., 1998), and in five croatian
cities (Peraica et al., 2001) regional differences have also
been observed.
Comparing our results with others from different coun-
tries, the levels of Coimbra inhabitants are higher than
those from Sweden-Visby, Norway-Oslo (Thuvander
et al., 2001) and Switzerland (Zimmerli and Dick, 1995).
Those values are lower than samples from Canada, United
Kingdom, and Italy. The mean concentration of Verride
samples is similar to that of Canada, but lower than that
of United Kingdom, Algeria, and Abidjan, Tunisia (Scott
et al., 1998; Thuvander et al., 2001; Zimmerli and Dick,
1995; Singare-Tigori et al., 2006).
The frequency of detection of 100% was also observed in
Sweden-Visby, Switzerland, Norway-Oslo, and Canada.
However, other countries, such Yugoslavia, Germany,
Croatia, and Tunisia showed detections oscillating between
6.6% and 98% (Marquardt and Frolich, 1992; Gareis et al.,
2001; Peraica et al., 1999; Singare-Tigori et al., 2006),
probably due to different limits of detection or limits of
quantification of the analytical methodology used. Data
disposable from bibliography shows that LODs vary
between 0.01 lg/L and 0.52 lg/L and LOQs between
0.05 lg/L and 0.78 lg/L (Thuvander et al., 2001; Jimenez
et al., 1998).
Comparing the OTA levels regarding gender in this
study with others from different countries, we conclude
that the levels found in women and men from Coimbra,
and in women from Ereira are higher than those found
in Sweden-Visby, Norway-Oslo (Thuvander et al., 2001),
Switzerland – North and South of the Alps (Zimmerli
and Dick, 1995), and Lebanon (Assaf et al., 2004). Mean
concentrations of women and men from Verride and men
from Ereira are higher than that of all of the referred
countries, with exception for men concentrations in
Switzerland – south of the Alps, whose levels are higher
than Verride women and Ereira men. However, mean con-
centration of Verride men is the highest.
The high levels found in Verride may cause concern,
once OTA is classified as possibly carcinogenic for humans
(group 2B) by International Agency for Research on Can-
cer (1993).
The results of the EDI obtained in our study are within
the range for tolerable daily intake of 0.2–4.2 ng/kg b.w.
per day established by Kuiper-Goodman and Scott in
1989 (Marquardt and Frolich, 1992), and below 5 ng/
kg b.w., the tolerable daily intake (TDI) estimated by the
Scientific Committee on Foods (SFC) of the European
Union, (2002).
None of the analyzed populations exceeded those
values. Although the mean daily intake of OTA in those
populations, the occasional samples with very highconcentrations of OTA urges strict control of OTA con-
tamination of food and feed.
EDI values in Portuguese populations are higher than
other European populations. In Germany, the EDIs for
adults are in the range of 0.5–0.6 ng/kg b.w. (Gareis
et al., 2001). In Croatian cities, the EDI was estimated to
be in the range from 0.24 ng/kg b.w. per day to 0.91 ng/
kg b.w. per day (Peraica et al., 1999). The intake in Oslo
and Visby were 0.24 and 0.28 ng/kg b.w. per day (Thuvan-
der et al., 2001). In 1994 in Canada, the EDI was estimated
as 1.2 ng/kg b.w. per day (Scott et al., 1998).Acknowledgements
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